Nuvation Bio Inc. Class A (NUVB) earnings
NUVB earnings moved a median of +0.43% by the close. Quarterly and annual NUVB reports and results, each read against the price at its own news timestamp. Back to the NUVB overview →
28 measured NUVB earnings events.
Where these NUVB earnings landedvs 28 measured NUVB earnings reactions
| Middle 50% of NUVB earnings reactions | -3.77% to +2.25% |
|---|---|
| Median reaction (to close) | +0.43% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 NUVB earnings events with a measured close landed between -3.77% and +2.25%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Nuvation Bio Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.20% | -7.71% | |
| Nuvation Bio Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | +2.20% | -7.71% | |
| Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 | Press release | +0.00% | -2.49% | |
| Form 10-Q Nuvation Bio Inc. For: Jun 30 | SEC filing · Form 10-Q | +4.95% | +0.82% | |
| Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | +4.95% | +0.82% | |
| Nuvation Bio to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026 | Press release | -0.70% | +1.09% | |
| Form 10-Q Nuvation Bio Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.91% | +9.28% | |
| Nuvation Bio Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -0.91% | +9.28% | |
| Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026 | Press release | +0.58% | -0.58% | |
| Form 10-K Nuvation Bio Inc. For: Dec 31 | SEC filing · Form 10-K | -8.61% | -8.40% | |
| Form 10-Q Nuvation Bio Inc. For: Sep 30 | SEC filing · Form 10-Q | -14.26% | -6.94% | |
| Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -14.26% | -6.94% | |
| Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025 | Press release | +1.90% | +14.40% | |
| Form 10-Q Nuvation Bio Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.66% | +0.43% | |
| Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -3.66% | +0.43% | |
| Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 | Press release | +0.40% | +0.00% | |
| Form 10-Q Nuvation Bio Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.25% | -5.41% | |
| Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +2.25% | -5.41% | |
| Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025 | Press release | +2.80% | -2.80% | |
| Form 10-K Nuvation Bio Inc. For: Dec 31 | SEC filing · Form 10-K | -3.46% | +7.45% | |
| Form 10-Q Nuvation Bio Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.46% | +1.55% | |
| Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | -4.46% | +1.55% | |
| Form 10-Q Nuvation Bio Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.18% | +2.25% | |
| Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -4.18% | +2.25% | |
| Form 10-Q Nuvation Bio Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.64% | -3.23% | |
| Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +2.64% | -3.23% | |
| Form 10-K/A Nuvation Bio Inc. For: Dec 31 | SEC filing · Form 10-K | +1.68% | +3.87% | |
| Form 10-K Nuvation Bio Inc. For: Dec 31 | SEC filing · Form 10-K | +2.69% | +19.89% |
Keep exploring
More NUVB: analyst actions → · SEC filings → · NUVB overview →